MoonLake Immunotherapeutics logo
MoonLake Immunotherapeutics
MLTX | NASDAQ
Chart Builder DCF Calculator
$11.73
-$0.77 (-6.16%)
At close: Nov 16, 2026, 4:00 PM ET
$11.73
$0.00 (0.00%)
After-hours: Nov 16, 2026, 7:30 PM ET

MoonLake Immunotherapeutics Institutional Ownership

Institutional ownership explained

Institutional Ownership

Net Inflow
Dollar & Volume Weighted
Total Institutions
187
Total Ownership
102.76%
Capital Flow
+$253.23M
Shares Change
+10.19M
Ownership Distribution
Institutions (99.99%)
Others (0.01%)

Institutional Sentiment

Overall: bullish
Equity Sentiment & Activity
bullish
New Positions
45
Increased Positions
117
Reduced Positions
45
Closed Positions
18
New (45)
Increased (117)
Reduced (45)
Closed (18)
Options Sentiment & Activity
bullish
Put/Call Ratio
0.375
Call Flow
1,431,100
Put Flow
536,700
Calls (73%)
Puts (27%)

Super Investors

Super Investor / Fund Ownership Portfolio Weight Shares Market Value
Point72 Asset Management LP
1.57%
-15.33%
0.02%
1.16M
14.57M
Renaissance Technologies LLC
0.87%
+132.42%
0.01%
643.27K
8.09M
Tudor Investment Corp ET AL
0.08%
-4.61%
< 0.01%
58.74K
738.36K

Top Shareholders

Institution Ownership Portfolio Weight Shares Market Value
Bvf Inc/il
21.65%
-3.57%
7.97%
-16.16%
16M
0.00%
311.54M
+4.45%
Deep Track Capital, LP
9.47%
+5.31%
1.98%
+1.67%
7M
+9.21%
136.27M
+14.07%
T. Rowe Price Investment Management, Inc.
5.79%
+100.00%
0.05%
+100.00%
4.28M
+100.00%
83.34M
+100.00%
Pro Membership

Stop Guessing, Start Knowing.

Cut through market noise with actionable insights that actually help you make confident investment decisions. No more endless research or gut-based guessing.

Unlimited access

Unlimited access to all data and tools, giving you the edge over everyone else in the market.

Proprietary Stock Rating Score

Evaluate stocks with our proprietary rating score based on fundamentals, economic moat, and sentiment.

Top Wall Street Analyst Ratings

Follow ratings from the best analysts on Wall Street to stay ahead of market moves.

Up to 30 years financial history

We deliver premium Wall Street data with top-tier accuracy and up to 30 years of history.

© 2026 bestshares.com. All rights reserved.

All data is for informational purposes only. bestshares.com is not a broker, dealer, or registered investment adviser, and nothing on this site is a recommendation to buy or sell any security.